Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Lotus Books Solid 2008; Still Needs Cash

publication date: Apr 16, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Lotus Pharmaceuticals (路坦制药有限公司) filed its 2008 financial report showing the company’s revenues, which totaled $73.8 million, were up 30% while net income rose 14% to $12.8 million or 27 cents per fully diluted share. The company said it expected to see “steady” growth in 2009. Unfortunately, Lotus ended 2008 with just $1.3 million in cash and working capital of $4.4 million with two big-dollar projects in the works. More details...

Stock Symbol: (OTCBB: LTUS)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
ChinaBio® Events
Shanghai, China
April 14-15, 2015

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors